Literature DB >> 22278997

Assessment of cognitive fluctuation in dementia: a systematic review of the literature.

David R Lee1, John-Paul Taylor, Alan J Thomas.   

Abstract

OBJECTIVE: Cognitive fluctuations (CF) are defined as spontaneous alterations in cognition, attention and arousal. They are a recognised feature of the dementias, especially dementia with Lewy bodies (DLB) and Parkinson's disease dementia. However, the accurate identification and assessment of CF presents a major clinical difficulty, with the operationalisation of the term 'cognitive fluctuation' remaining elusive, despite several attempts to identify, quantify and assess the phenomenon. No published reviews of CF in dementia exist despite this being an important clinical phenomenon and a core diagnostic feature of DLB.
METHODS: We systematically explored the literature and measures available for the definition, assessment and quantification of CF in the dementias.
RESULTS: We identified only three psychometric measures, which have been developed for the identification and assessment of CF, and these have not been adequately tested as yet for reliability and validity. DISCUSSION AND
CONCLUSIONS: We conclude that further research is warranted into the assessment of CF, and this is timely given the increasing recognition of the clinical importance of CF as a dementia symptom, particularly in the Lewy body dementias.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22278997     DOI: 10.1002/gps.2823

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  20 in total

Review 1.  Psychiatric issues in cognitive impairment.

Authors:  Dag Aarsland; John-Paul Taylor; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

2.  Fluctuations in cognition and alertness vary independently in dementia with Lewy bodies.

Authors:  Donald L Bliwise; Michael K Scullin; Lynn Marie Trotti
Journal:  Mov Disord       Date:  2013-10-22       Impact factor: 10.338

Review 3.  Outcome Measures for Dementia With Lewy Body Clinical Trials: A Review.

Authors:  Bhavana Patel; David J Irwin; Daniel Kaufer; Bradley F Boeve; Angela Taylor; Melissa J Armstrong
Journal:  Alzheimer Dis Assoc Disord       Date:  2022 Jan-Mar 01       Impact factor: 2.357

Review 4.  Lewy Body Dementias: Controversies and Drug Development.

Authors:  Shannon Y Chiu; Dawn Bowers; Melissa J Armstrong
Journal:  Neurotherapeutics       Date:  2021-12-02       Impact factor: 6.088

Review 5.  Lewy body dementias.

Authors:  Zuzana Walker; Katherine L Possin; Bradley F Boeve; Dag Aarsland
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

6.  Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences.

Authors:  Stefano Delli Pizzi; Raffaella Franciotti; John-Paul Taylor; Astrid Thomas; Armando Tartaro; Marco Onofrj; Laura Bonanni
Journal:  Cereb Cortex       Date:  2014-09-26       Impact factor: 5.357

7.  Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies.

Authors:  Laura Bonanni; Bernardo Perfetti; Stefania Bifolchetti; John-Paul Taylor; Raffaella Franciotti; Lucilla Parnetti; Astrid Thomas; Marco Onofrj
Journal:  Neurobiol Aging       Date:  2014-07-15       Impact factor: 4.673

8.  Cognitive fluctuations in connection to dysgraphia: a comparison of Alzheimer's disease with dementia Lewy bodies.

Authors:  Emanuela Onofri; Marco Mercuri; Giuseppe Donato; Serafino Ricci
Journal:  Clin Interv Aging       Date:  2015-03-26       Impact factor: 4.458

9.  Can we clinically diagnose dementia with Lewy bodies yet?

Authors:  Yue Huang; Glenda Halliday
Journal:  Transl Neurodegener       Date:  2013-02-11       Impact factor: 8.014

10.  Identifying patients with poststroke mild cognitive impairment by pattern recognition of working memory load-related ERP.

Authors:  Xiaoou Li; Yuning Yan; Wenshi Wei
Journal:  Comput Math Methods Med       Date:  2013-10-23       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.